Activist 13D/13G Filings - Growth Equity Opportunities V LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-05-12
1:57 pm
Sale
13DRegulus Therapeutics Inc.
RGLS
Growth Equity Opportunities V LLC1,945,579
9.99%
-12,636,942decrease
(-86.66%)
View
2023-03-09
4:10 pm
Sale
13DMEI Pharma, Inc.
MEIP
Growth Equity Opportunities V LLC0
0%
-9,963,216decrease
(Position Closed)
View
2022-07-22
4:06 pm
Sale
13DCTI BioPharma Corp.
CTIC
Growth Equity Opportunities V LLC0
0%
-9,613,101decrease
(Position Closed)
View
2022-06-17
5:10 pm
Purchase
13DCTI BioPharma Corp.
CTIC
Growth Equity Opportunities V LLC9,613,101
8.8%
2,228,285increase
(+30.17%)
View
2021-12-09
2:58 pm
Purchase
13DRegulus Therapeutics Inc.
RGLS
Growth Equity Opportunities V LLC14,582,521
9.99%
12,530,067increase
(+610.49%)
View
2021-11-19
06:44 am
Sale
13DTrillium Therapeutics Inc.
TRIL
Growth Equity Opportunities V LLC0
0%
-6,586,363decrease
(Position Closed)
View
2021-08-31
6:43 pm
Unchanged
13DTrillium Therapeutics Inc.
TRIL
Growth Equity Opportunities V LLC6,586,363
6.3%
0
(Unchanged)
View
2020-03-12
08:03 am
Purchase
13DCTI BioPharma Corp.
CTIC
Growth Equity Opportunities V LLC7,384,816
9.99%
3,634,816increase
(+96.93%)
View
2020-02-13
10:46 am
Unchanged
13DCTI BioPharma Corp.
CTIC
Growth Equity Opportunities V LLC3,750,000
6.5%
0
(Unchanged)
View
2020-02-04
5:19 pm
Purchase
13DTrillium Therapeutics Inc.
TRIL
Growth Equity Opportunities V LLC6,586,363
8.7%
4,462,453increase
(+210.11%)
View
2019-12-30
3:47 pm
Purchase
13DMEI Pharma, Inc.
MEIP
Growth Equity Opportunities V LLC9,963,216
9.8%
2,937,575increase
(+41.81%)
View
2019-05-15
2:35 pm
Sale
13DRegulus Therapeutics Inc.
RGLS
Growth Equity Opportunities V LLC2,052,454
9.99%
-8,936,556decrease
(-81.32%)
View
2019-03-04
3:45 pm
Purchase
13DTrillium Therapeutics Inc.
TRIL
Growth Equity Opportunities V LLC2,123,910
9.99%
873,910increase
(+69.91%)
View